PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Down 30.7% in September

PURE Bioscience, Inc. (OTCMKTS:PURE) was the target of a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 20,800 shares, a drop of 30.7% from the August 31st total of 30,000 shares. Based on an average daily trading volume, of 39,700 shares, the days-to-cover ratio is presently 0.5 days.

PURE Bioscience Price Performance

PURE Bioscience stock remained flat at $0.07 during mid-day trading on Friday. 85,000 shares of the company’s stock were exchanged, compared to its average volume of 28,876. The business’s 50-day simple moving average is $0.07 and its 200-day simple moving average is $0.08. PURE Bioscience has a 12 month low of $0.06 and a 12 month high of $0.17. The company has a market cap of $7.83 million, a P/E ratio of -1.17 and a beta of 0.06.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.